Related Experiment Video
Updated: May 5, 2026
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Rhabdomyosarcoma of the biliary tract in a child: a case report
Tang Ran1, Chen Gong2, Dong Rui2
1Department of Pediatric Surgery, Anhui Provincial Children's Hospital, Hefei, China.
Insights
Pediatric biliary tract rhabdomyosarcoma (BRMS) is rare and often misdiagnosed. Endoscopic retrograde cholangiopancreatography (ERCP) aids diagnosis, with surgery and chemotherapy offering successful treatment for this rare pediatric cancer.
Area of Science:
- Pediatric Oncology
- Gastrointestinal Surgery
- Diagnostic Imaging
Background:
- Pediatric rhabdomyosarcoma of the biliary tract (BRMS) is an exceptionally rare malignancy.
- Early symptoms are often non-specific, leading to diagnostic challenges and potential misdiagnosis, such as choledocholithiasis.
- Distinguishing BRMS from other pediatric biliary conditions via imaging can be difficult.
Abstract:
Pediatric rhabdomyosarcoma of the biliary tract (BRMS) is extremely rare. Here, we present a case of a 2-year-old child who was initially misdiagnosed with choledocholithiasis upon admission. The diagnosis was later confirmed as BRMS through endoscopic retrograde cholangiopancreatography (ERCP). The patient was cured through surgery followed by chemotherapy. Due to the lack of specific early symptoms and the challenges in imaging differentiation, particularly in pediatric patients, clinical awareness of this condition needs to be heightened. Our findings indicate that ERCP is currently the optimal diagnostic tool for this disease, and a combination of surgery and chemotherapy can yield better therapeutic outcomes.
